 |
|
|
| |
Week 96 Efficacy and Safety of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF) in Older HIV-Infected Virologically-Suppressed Adults - eGFR ≥50
|
| |
| |
Reported by Jules Levin
7th International Workshop on HIV & Aging, September 26-27, 2016, Washington DC
D Goldstein1, M Thompson2, D Ward3, C Brinson4, G Crofoot5, C Kinder6, Y-P Liu7, J Ryu7, I McNicholl7, R Haubrich7, A Weinberg7, S McCallister7
1Whitman-Walker Health, Washington, DC; 2AIDS Research Consortium of Atlanta, Atlanta, GA; 3Dupont Circle Physicians Group, Washington, DC; 4Central Texas Clinical Research, Austin, TX; 5The Crofoot Research Center, Inc, Houston, TX; 6The Kinder Medical Group, Miami, FL; 7Gilead Sciences, Foster City, CA
|
| |
|
|
|
|
|
